DISCOUNT-ZERTIFIKAT - AMGEN Share Price

DE000KH22WR1

Market Closed - Deutsche Boerse AG 11:00:51 27/05/2024 pm IST
202.1 ^EUR	-0.05%

Current month	-1.21%
1 month	-0.94%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart AMGEN INC.

Latest news about AMGEN INC.

Supreme Court Holds Invalid Cholesterol Drug Patent That Covered Millions Of Undisclosed Antibodies	27/05	AQ
Amgen : An Underrecognized Risk Factor for Heart Disease	23/05	PU
Improving treatment responses to solid tumours with trispecific TCEs	23/05	AQ
Amgen : From the Office to the Lab, Amgen Uses AI Tools to Unlock Innovation	22/05	PU

More news

Quotes 5-day view

Date	Price	Change
27/24/27	202.1	-0.05%
24/24/24	202.2	-0.28%
23/24/23	202.8	+0.20%
22/24/22	202.4	+0.13%
21/24/21	202.1	+0.14%

Delayed Quote Deutsche Boerse AG

Last update May 27, 2024 at 11:00 pm IST

More quotes

Static data

Product type	Discount Certificates
Buy / Sell	CALL
Underlying	AMGEN INC.
Issuer	Citi
WKN	KH22WR
ISIN	DE000KH22WR1
Date issued	31/01/2023
Maturity	06/06/2024 (10 Days)
Parity	1 : 1
Emission price	181.6 €
Emission volume	N/A
Settlement	cash
Currency	EUR

Technical Indicators

Highest since issue	205 €
Lowest since issue	176.4 €

Company Profile

Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows: - drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.; - other (5.8%): primarily royalties. The United States account for 70.3% of net sales.

Sector

More about the company

Ratings for Amgen Inc.

Trading Rating

Investor Rating

ESG Refinitiv

C+

More Ratings

Consensus: Amgen Inc.

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

305.8 USD

Average target price

316.3 USD

Spread / Average Target

+3.41%

Consensus